Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Ono Pharmaceutical Co. Lt...

    OTC: OPHLY · Real-Time Price · USD
    3.42
    -0.07 (-2.01%)
    At close: Jun 06, 2025, 3:08 PM

    Ono Pharmaceutical Statistics

    Share Statistics

    Ono Pharmaceutical has 1.41B shares outstanding. The number of shares has increased by 3.01% in one year.

    Shares Outstanding

    n/a
    		 1.41B

    Shares Change (YoY)

    n/a
    		 3.01%

    Shares Change (QoQ)

    n/a
    		 0.01%

    Owned by Institutions (%)

    n/a
    		 0.01%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 1,348

    FTD / Avg. Volume

    n/a
    		 0.48%

    Short Selling Information

    The latest short interest is 13.46K, so 0% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 13.46K

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is 9.27 and the forward PE ratio is 0.07. Ono Pharmaceutical's PEG ratio is 0.04.

    PE Ratio

    n/a
    		 9.27

    Forward PE

    n/a
    		 0.07

    PS Ratio

    n/a
    		 2.36

    Forward PS

    n/a
    		 0

    PB Ratio

    n/a
    		 1.5

    P/FCF Ratio

    n/a
    		 13.2

    PEG Ratio

    n/a
    		 0.04
    Financial Ratio History

    Enterprise Valuation

    Ono Pharmaceutical has an Enterprise Value (EV) of 238.03B.

    EV / Sales

    n/a
    		 0.47

    EV / EBITDA

    n/a
    		 1.33

    EV / EBIT

    n/a
    		 2.15

    EV / FCF

    n/a
    		 2.65

    Financial Position

    The company has a current ratio of 3.99, with a Debt / Equity ratio of 0.01.

    Current Ratio

    n/a
    		 3.99

    Quick Ratio

    n/a
    		 3.52

    Debt / Equity

    n/a
    		 0.01

    Debt / EBITDA

    n/a
    		 0.05

    Debt / FCF

    n/a
    		 0.1

    Interest Coverage

    n/a
    		 712.24

    Financial Efficiency

    Return on Equity is 16.14% and Return on Invested Capital is 15.7%.

    Return on Equity

    n/a
    		 16.14%

    Return on Assets

    n/a
    		 14.01%

    Return on Invested Capital

    n/a
    		 15.7%

    Revenue Per Employee

    n/a
    		 $130,462,496.76

    Profits Per Employee

    n/a
    		 $33,214,897.48

    Employee Count

    n/a
    		 3,853

    Asset Turnover

    n/a
    		 0.55

    Inventory Turnover

    n/a
    		 2.61

    Taxes

    Income Tax

    n/a
    		 35.69B

    Effective Tax Rate

    n/a
    		 21.8%

    Stock Price Statistics

    The stock price has increased by -26.64% in the last 52 weeks. The beta is 0.19, so Ono Pharmaceutical's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.19

    52-Week Price Change

    n/a
    		 -26.64%

    50-Day Moving Average

    n/a
    		 3.67

    200-Day Moving Average

    n/a
    		 3.87

    Relative Strength Index (RSI)

    n/a
    		 44.68

    Average Volume (20 Days)

    n/a
    		 282,303

    Income Statement

    In the last 12 months, Ono Pharmaceutical had revenue of 502.67B and earned 127.98B in profits. Earnings per share was 88.86.

    Revenue

    n/a
    		 502.67B

    Gross Profit

    n/a
    		 375.55B

    Operating Income

    n/a
    		 163.1B

    Net Income

    n/a
    		 127.98B

    EBITDA

    n/a
    		 178.44B

    EBIT

    n/a
    		 163.96B

    Earnings Per Share (EPS)

    n/a
    		 88.86
    Full Income Statement

    Balance Sheet

    The company has 166.14B in cash and 8.86B in debt, giving a net cash position of 157.28B.

    Cash & Cash Equivalents

    n/a
    		 166.14B

    Total Debt

    n/a
    		 8.86B

    Net Cash

    n/a
    		 157.28B

    Retained Earnings

    n/a
    		 768.18B

    Total Assets

    n/a
    		 1,083.7B

    Working Capital

    n/a
    		 134.54B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 110.66B and capital expenditures -20.83B, giving a free cash flow of 89.83B.

    Operating Cash Flow

    n/a
    		 110.66B

    Capital Expenditures

    n/a
    		 -20.83B

    Free Cash Flow

    n/a
    		 89.83B

    FCF Per Share

    n/a
    		 187.12
    Full Cash Flow Statement

    Margins

    Gross margin is 74.71%, with operating and profit margins of 32.45% and 25.46%.

    Gross Margin

    n/a
    		 74.71%

    Operating Margin

    n/a
    		 32.45%

    Pretax Margin

    n/a
    		 32.57%

    Profit Margin

    n/a
    		 25.46%

    EBITDA Margin

    n/a
    		 35.5%

    EBIT Margin

    n/a
    		 32.45%

    FCF Margin

    n/a
    		 17.87%

    Dividends & Yields

    OPHLY pays an annual dividend of $0.26, which amounts to a dividend yield of 2.77%.

    Dividend Per Share

    n/a
    		 $0.26

    Dividend Yield

    n/a
    		 2.77%

    Dividend Growth (YoY)

    n/a
    		 24.41%

    Payout Ratio

    n/a
    		 102.79%

    Earnings Yield

    n/a
    		 10.79%

    FCF Yield

    n/a
    		 22.72%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for OPHLY.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 $2221.5

    Lynch Upside

    n/a
    		 63920.17%

    Graham Number

    n/a
    		 3147.5

    Graham Upside

    n/a
    		 90606.05%

    Stock Splits

    The last stock split was on Apr 4, 2016. It was a forward split with a ratio of 3:1.

    Last Split Date

    n/a
    		 Apr 4, 2016

    Split Type

    n/a
    		 forward

    Split Ratio

    n/a
    		 3:1

    Scores

    Altman Z-Score

    n/a
    		 2.08

    Piotroski F-Score

    n/a
    		 5

    Add to Watchlist